Tissue factor is the receptor for plasminogen type 1 on 1-LN human prostate cancer cells
- PMID: 12036889
- DOI: 10.1182/blood.v99.12.4562
Tissue factor is the receptor for plasminogen type 1 on 1-LN human prostate cancer cells
Abstract
Tissue factor (TF), the initiator of the extrinsic pathway of coagulation, binds plasminogen (Pg) with high affinity through an interaction between kringles 1-3 of Pg and the extracellular domain of TF. We investigated the binding of Pg type 1 (Pg 1) and Pg type 2 (Pg 2) to highly invasive, TF-expressing, 1-LN human prostate tumor cells and to TF isolated from 1-LN cell membranes. Pg 1, containing both N-linked and O-linked oligosaccharide chains, bound to isolated TF with high affinity, whereas Pg 2, containing only one O-linked oligosaccharide chain, did not bind to TF. Although Pg 1 and Pg 2 bind to 1-LN cells, only anti-TF antibodies inhibited the binding of Pg 1, suggesting that TF functions as the receptor for Pg 1 on 1-LN cells. Binding of Pg 1 to isolated TF was inhibited by 6-aminohexanoic acid and alpha-methylmannoside, suggesting that Pg 1 L-lysine binding sites and the biantennary, mannose-containing N-linked oligosaccharide chain are involved in this interaction. Binding of Pg 1 to 1-LN cells promoted activation by receptor-bound urinary-type Pg activator (u-PA) and initiated a Ca(++) signaling cascade. In previous studies we demonstrated that the Pg 2 O-linked carbohydrate chain is essential for its binding to CD26 on 1-LN cells. The current studies suggest that Pg oligosaccharide chains regulate the binding of Pg 1 and Pg 2 to separate receptors on the cell surface.
Similar articles
-
Tissue factor regulates plasminogen binding and activation.Blood. 1998 Mar 15;91(6):1987-98. Blood. 1998. PMID: 9490681
-
Cell surface adenosine deaminase binds and stimulates plasminogen activation on 1-LN human prostate cancer cells.J Biol Chem. 2004 May 14;279(20):20993-8. doi: 10.1074/jbc.M401023200. Epub 2004 Mar 11. J Biol Chem. 2004. PMID: 15016824
-
Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.Thromb Haemost. 2002 Dec;88(6):1054-9. Thromb Haemost. 2002. PMID: 12529759
-
Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptor.Front Biosci. 2008 Jan 1;13:1610-8. doi: 10.2741/2785. Front Biosci. 2008. PMID: 17981653 Review.
-
Posttranslational modifications of tissue factor.Front Biosci (Elite Ed). 2012 Jan 1;4(1):381-91. doi: 10.2741/385. Front Biosci (Elite Ed). 2012. PMID: 22201880 Free PMC article. Review.
Cited by
-
Proteoform-Resolved Profiling of Plasminogen Activation Reveals Novel Abundant Phosphorylation Site and Primary N-Terminal Cleavage Site.Mol Cell Proteomics. 2024 Jan;23(1):100696. doi: 10.1016/j.mcpro.2023.100696. Epub 2023 Dec 13. Mol Cell Proteomics. 2024. PMID: 38101751 Free PMC article.
-
The voltage-dependent anion channel (VDAC) binds tissue-type plasminogen activator and promotes activation of plasminogen on the cell surface.J Biol Chem. 2013 Jan 4;288(1):498-509. doi: 10.1074/jbc.M112.412502. Epub 2012 Nov 16. J Biol Chem. 2013. PMID: 23161549 Free PMC article.
-
Biophysical Mechanisms Mediating Fibrin Fiber Lysis.Biomed Res Int. 2017;2017:2748340. doi: 10.1155/2017/2748340. Epub 2017 May 28. Biomed Res Int. 2017. PMID: 28630861 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous